DC Role: 
Project Partner
1 Jan 2014 - 31 Dec 2017
Innovative Medicines Initiative, European Commission (IMI)


The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (3 days ago)
RT @eNanoMapper: the first tutorial is migrated from Word/OpenOffice to Markdown! :) https://t.co/TYaikuqm0Y https://t.co/QHgctuMxBi
Douglas Connect (6 days ago)
RT @barryhardy: @DouglasConn Poster 783 by @dramaziz of An integrated testing strategy for quantitative #skin #sensitization #risk #assessm…
Douglas Connect (6 days ago)
DC provides an open implementation of the integrated testing strategy (ITS) that assesses skin sensitisation. Our I… https://t.co/DhFJ8ycqJA
Douglas Connect (1 week ago)
Jeff Wiseman is our first large Toblerone winner at SOT-ToxExpo 2018 🙂 you can stop by Booth (#1669) for a data cou… https://t.co/GAO6hxdZ1n
Douglas Connect (1 week ago)
EU_ToxRisk & Douglas Connect adopt data API and data explorer concept for internal data sharing. Stop by Booth 1669… https://t.co/8TeLYHQxfX

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com